ACRV

Acrivon Therapeutics
$1.56
−$0.04 (−2.5%)Jul 27, 2026
0.5PoorMoatMint rating

MoatMint rates Acrivon Therapeutics (ACRV) 0.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.7 out of 10.

Key metrics

The numbers that frame ACRV today
Market cap
$66.77M
P/E (TTM)
-0.9
EV / FCF
-0.5
ROIC
-89.8%
Div yield
0%
Debt / equity
0.0
52wk Low
$1.20
52wk High
$3.56

ACRV stock rating

How ACRV scores on quality, value, growth, momentum and financial health
0.5out of 10
Low overallNeutral business, expensive priceTop 95% of ~5,000 US stocks
QualityPoor1.7/10
GrowthPoor0.9/10
MomentumFair3.3/10
ValuePoor0.2/10
Financial HealthPoor1.5/10

Growth

Revenue and earnings trend for ACRV
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ACRV
Is Acrivon Therapeutics a good buy?
No. Acrivon Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Acrivon Therapeutics is selling at a very high price.
What is the market capitalization of ACRV?
Acrivon Therapeutics's market capitalization is $66.77M.
What is the P/E ratio for ACRV stock?
Acrivon Therapeutics's current P/E ratio is -0.9.
What is the 52-week high for ACRV stock?
The 52-week high for Acrivon Therapeutics is $3.56. The current close of $1.56 is 56.2% below that high.
What is the 52-week low for ACRV stock?
The 52-week low for Acrivon Therapeutics is $1.20. The current close of $1.56 is 30% above that low.
Does ACRV stock pay dividends?
Acrivon Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ACRV?
Acrivon Therapeutics's Debt / Equity ratio is 0.03.